Intermediates of isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity

MDE20231011A1Undetermined Publication Date: 2023-11-30ASTEX THERAPEUTICS LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MDE20231011T
Authority / Receiving Office
MD · MD
Patent Type
Applications
Current Assignee / Owner
Priority Date
2015-09-29
Filing Date
2016-09-29
Publication Date
2023-11-30
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.